Gastroesophageal Reflux Disease
📧 Sign up to get email alerts when something new happens for Gastroesophageal Reflux Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-05-07Clinical Trial Update: The CONQUEST-Study. Evaluation of Clinical Endpoints for Treatment-induced Changes in GERD-related Symptoms (BY1023/NL511) [Phase 4]
A Phase 4 clinical trial evaluating treatment-induced changes in GERD-related symptoms (BY1023/NL511) conducted by Takeda has been terminate…
-
CLINICAL_TRIALS trial_result · 2012-05-07Clinical Trial Update: Comparison of the Classical Healing Concept With the Complete Remission Concept After Treatment With Pantoprazole in Adult Patients With Erosive GERD (Gastroesophageal Reflux Disease) (BY1023/M3-342) [Phase 4]
Phase 4 clinical trial updating a comparison of healing concepts after pantoprazole treatment in adults with erosive gastroesophageal reflux…
-
CLINICAL_TRIALS withdrawal · 2012-04-20Clinical Trial Update: Longitudinal Study of Children With a Chronic Cough and the Impact of Gastroesophageal Reflux [Phase 3]
This Phase 3 pediatric study on chronic cough and gastroesophageal reflux has been withdrawn.
-
FDA approval · 2012-04-19FDA Approved: OMEPRAZOLE AND SODIUM BICARBONATE — Supplemental Application (Oceanside Pharmaceuticals)
The FDA approved Oceanside Pharmaceuticals' supplemental application for an omeprazole and sodium bicarbonate product, updating its labeling…
-
CLINICAL_TRIALS withdrawal · 2012-04-19Clinical Trial Update: Predictors of Proton Pump Inhibitor (PPI) Response in Eosinophilic Esophagitis [Phase 1, Phase 2]
A Phase 1/Phase 2 clinical trial evaluating predictors of proton pump inhibitor response in eosinophilic esophagitis and gastroesophageal re…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2012-04-18FDA Approved: LANSOPRAZOLE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva Pharmaceuticals USA, Inc.'s supplemental application for lansoprazole, authorizing the marketing of a generic lansoprazole…
-
CLINICAL_TRIALS trial_result · 2012-04-17Clinical Trial Update: The Study to Describe Symptom Control and Impact on Daily Life in Gastroesophageal Reflux Disease (GERD) Patients
A completed AstraZeneca-sponsored clinical trial update describing symptom control and impact on daily life in patients with gastroesophagea…
-
FDA approval · 2012-04-16FDA Approved: LANSOPRAZOLE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for Lansoprazole from Teva Pharmaceuticals USA, Inc. The submission concerns a supplemental chan…
-
CLINICAL_TRIALS trial_result · 2012-04-13Clinical Trial Update: Double-blind Comparative Study of E3810 Tablets (10 or 20 mg b.i.d.) to Evaluate Efficacy and Safety in Patients With Refractory Reflux Esophagitis [Phase 2, Phase 3]
A double-blind study comparing E3810 tablets (10 mg or 20 mg twice daily) to evaluate efficacy and safety in patients with refractory reflux…
-
CLINICAL_TRIALS trial_result · 2012-04-05Clinical Trial Update: Study to Evaluate the Pharmacokinetics and Safety of Dexlansoprazole in Pediatric Subjects With Symptomatic Gastroesophageal Reflux Disease [Phase 1]
Phase 1 study evaluating the pharmacokinetics and safety of dexlansoprazole in pediatric subjects with symptomatic gastroesophageal reflux d…
-
FDA approval · 2012-03-23FDA Approved: OMEPRAZOLE — Supplemental Application (Apotex Corp)
FDA approves Apotex Corp's supplemental application for omeprazole (generic) under ANDA076048. This authorizes the marketing of a generic om…
-
CLINICAL_TRIALS trial_result · 2012-03-23Clinical Trial Update: Intraoperative Use of Dexketoprofen Trometamol, Pethidine Hcl, Tramadol Hcl and Their Combinations for Postoperative Pain Management in Laparoscopic Nissen Fundoplication [Phase 4]
Phase 4 clinical trial evaluating intraoperative analgesic regimens—dexketoprofen trometamol, pethidine hydrochloride, tramadol hydrochlorid…
-
CLINICAL_TRIALS trial_result · 2012-03-22Clinical Trial Update: Detection of Minimal Change Esophagitis by I-scan
A completed clinical trial evaluating detection of minimal change esophagitis using I-scan in patients with gastroesophageal reflux disease …
-
FDA approval · 2012-03-14FDA Approved: METOCLOPRAMIDE HYDROCHLORIDE — Supplemental Application (Chartwell Governmental & Specialty RX, LLC.)
The FDA approved a supplemental application for metoclopramide hydrochloride from Chartwell Governmental & Specialty RX, LLC., signaling an …
-
CLINICAL_TRIALS trial_result · 2012-03-14Clinical Trial Update: Pharmacodynamic and Pharmacokinetic Study of E3710 Following Oral Administration to Healthy, Male, Japanese Subjects [Phase 1]
Phase 1 pharmacodynamic and pharmacokinetic study of E3710 in healthy Japanese male volunteers has completed.
-
CLINICAL_TRIALS research · 2012-03-12Clinical Trial Update: Is Laparoscopic Fundoplication Better Than Open Fundoplication in Children ? [NA]
The clinical trial comparing laparoscopic versus open fundoplication in children with gastroesophageal reflux disease was terminated.
-
FDA approval · 2012-03-08FDA Approved: METOCLOPRAMIDE — Supplemental Application (Ipca Laboratories Limited)
FDA approved a supplemental application for metoclopramide from Ipca Laboratories Limited.
-
FDA approval · 2012-02-29FDA Approved: ACID REDUCER — Original Application (WinCo Foods, LLC)
FDA approved an original application for a generic ranitidine hydrochloride product called ACID REDUCER by WinCo Foods, LLC.
-
CLINICAL_TRIALS trial_result · 2012-02-24Clinical Trial Update: Safety, Tolerability and Pharmacokinetics of Single Rising Doses of YF476, a Gastrin Antagonist, in Healthy Men [Phase 1]
Phase 1 study assessing safety, tolerability, and pharmacokinetics of single rising doses of YF476, a gastrin antagonist, in healthy male vo…
-
CLINICAL_TRIALS trial_result · 2012-02-22Clinical Trial Update: Gastroesophageal Reflux Disease (GERD)/Nighttime Heartburn and Driving Performance [NA]
A completed clinical trial evaluating the impact of GERD/nighttime heartburn on driving performance, sponsored by David A. Johnson, MD.
-
FDA approval · 2012-02-16FDA Approved: OMEPRAZOLE — Supplemental Application (Lannett Company, Inc.)
FDA approved a supplemental application for omeprazole from Lannett Company, Inc., authorizing a generic omeprazole product.
-
FDA approval · 2012-02-14FDA Approved: OMEPRAZOLE — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for omeprazole from Sandoz Inc, confirming an update to the approved generic product labeling. This …
-
FDA approval · 2012-02-13FDA Approved: OMEPRAZOLE — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for omeprazole submitted by Sandoz Inc under ANDA075757 (generic omeprazole).
-
FDA approval · 2012-02-09FDA Approved: OMEPRAZOLE — Supplemental Application (Quallent Pharmaceuticals Health LLC)
The FDA approved a supplemental application for a generic omeprazole product from Quallent Pharmaceuticals Health LLC under ANDA075576. This…
-
CLINICAL_TRIALS trial_result · 2012-02-02Clinical Trial Update: A Study of Disposable Transnasal Esophagoscope
A completed clinical trial studying a disposable transnasal esophagoscope, sponsored by Yonsei University, evaluating conditions including g…